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Abstract
Background: To assess the risk of all nanomaterials (NMs) on a case-by-case basis is challenging in terms of
financial, ethical and time resources. Instead a more intelligent approach to knowledge gain and risk assessment
is required.
Methods: A framework of future research priorities was developed from the accorded opinion of experts covering
all major stake holder groups (government, industry, academia, funders and NGOs). It recognises and stresses the
major topics of physicochemical characterisation, exposure identification, hazard identification and modelling
approaches as key components of the current and future risk assessment of NMs.
Results: The framework for future research has been developed from the opinions of over 80 stakeholders, that
describes the research priorities for effective development of an intelligent testing strategy (ITS) to allow risk
evaluation of NMs. In this context, an ITS is a process that allows the risks of NMs to be assessed accurately,
effectively and efficiently, thereby reducing the need to test NMs on a case-by-case basis.
For each of the major topics of physicochemical characterisation, exposure identification, hazard identification and
modelling, key-priority research areas are described via a series of stepping stones, or hexagon diagrams structured
into a time perspective. Importantly, this framework is flexible, allowing individual stakeholders to identify where
their own activities and expertise are positioned within the prioritisation pathway and furthermore to identify how
they can effectively contribute and structure their work accordingly. In other words, the prioritisation hexagon
diagrams provide a tool that individual stakeholders can adapt to meet their own particular needs and to deliver
an ITS for NMs risk assessment. Such an approach would, over time, reduce the need for testing by increasing the
reliability and sophistication of in silico approaches.
The manuscript includes an appraisal of how this framework relates to the current risk assessment approaches and
how future risk assessment could adapt to accommodate these new approaches. A full report is available in
electronic format (pdf) at http://www.nano.hw.ac.uk/research-projects/itsnano.html.
Conclusion: ITS-NANO has delivered a detailed, stakeholder driven and flexible research prioritisation (or strategy) tool,
which identifies specific research needs, suggests connections between areas, and frames this in a time-perspective.
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throughput, Mode-of-action
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Background
Prioritisation of research activities and funding is a perpet-
ual issue, especially when it comes to applied research, i.e.
research that directly affects society. With respect to
Nanotechnology, the development and adaptation of
methods to assess the safety of nanomaterials (NMs) are
currently under pressure as NMs are being made and de-
veloped in increasing types and quantities [1]. Stake-
holders, including academics, industry, regulators and
NGOs therefore require a streamlined process, known as
an intelligent testing strategy (ITS) that allows the risks of
NMs to be performed accurately, effectively and efficiently
[2-4]. Accurately means that the correct conclusion re-
garding risk is made, while effectively means that appro-
priate tools/protocols are available to achieve the risk
assessment, and efficiently means that the assessment
does not take too long or cost too much money.
In 2012 the European Commission funded a project,
ITS-NANO, to prioritise research that would allow de-
velopment of an ITS for NMs safety (http://www.nano.
hw.ac.uk/research-projects/itsnano.html). The ambition
was to develop research prioritisation that would be
adopted and recognised by all relevant stakeholders. The
ITS-NANO consortium included experts from nine differ-
ent European organisations (see the author details), who
engaged with over 80 expert representatives from aca-
demia, industry, regulators, funders and NGOs. Interaction
was facilitated via two workshops to assess the stakeholder
needs, to identify and confirm gaps in knowledge and,
based upon these different sources of information, to de-
liver a stakeholder driven research prioritisation document.
The following manuscript outlines the approach taken
to assess gaps in knowledge, to identify the research re-
quired to fill these gaps, and finally how to prioritise
these gaps according to the needs and opinions of a
broad spectrum of stakeholders. In doing so ITS-NANO
provides a tool to organise and prioritise research activ-
ities that will lead to an ITS which will be fit for purpose
and develops with time.
Results and discussion
To assess the risk of every NMs on a case-by-case basis
for every possible human and environmental exposure
scenario [1] is impossible. Instead a more intelligent ap-
proach to knowledge gain and risk assessment is required
[2-4]. Currently we lack the knowledge required to accur-
ately predict the risks of NMs using either empirical test-
ing or modelling approaches. Therefore research is
required that will drive the field forward in a focused way
that will deliver such an intelligent approach.
Gap analysis
A gap analysis of the available knowledge required to as-
sess the risks of NMs and to develop an intelligent
testing strategy was conducted. The gaps covered physi-
cochemical characterisation, exposure assessment, haz-
ard assessment, grouping/ranking/modelling approaches
and risk assessment methodologies/frameworks. Owing
to the large number of publications pertaining to hazard,
these were represented and analysed via a series of heat
map tables (Figure 1). The heat maps proved to be a
novel and extremely useful tool for visually identifying
where gaps in our knowledge of NMs safety exist [5].
The risk assessment paradigm
The traditional risk assessment paradigm used for che-
micals includes assessment of hazard and exposure, by
taking into account physicochemical information. The
ITS presented here also uses the same risk assessment
approach, but it increases the emphasis on thorough
physicochemical characterisation of NMs compared to
the approach currently used. This means that the risk
assessment paradigm was adapted, where necessary, to
take account of NM-specific or NM-relevant factors,
such as size, shape and surface characteristics. All three
aspects (physicochemical, exposure and hazard) com-
bined with cross-cutting grouping/ranking were defined
and used to identify the research needed to deliver the
tools required for robust risk assessment of NMs.
Defining the ITS-NANO vision and time frame
Based upon the opinions of the project partners with in-
put from the stakeholders workshop (Edinburgh, 2012),
the ITS-NANO vision was identified as a way forward in
which ‘there is a knowledge-based sustainable devel-
opment of engineered NMs, that is based upon robust
procedures for effective management of the risks of
existing and future NMs’ [6].
In order to identify the research priorities to achieve
the ITS, the actual ITS ambition itself was outlined. In
the short term (less than 5 years) this includes improv-
ing the understanding of the relationships between phys-
icochemical, exposure and hazard characteristics (e.g. by
determining the mode-of-action underlying the hazard-
ous effects), primarily to promote the development of
grouping and or ranking approaches for NMs and to
enable design of in vitro and high through-put screen-
ing tools that target biological key processes. Such
approaches are required to improve the efficiency of
NM screening and risk assessment. In the mid-term
(5–10 years) the ambition includes an understanding of
the relevance to risk assessment of less demanding, costly
and time consuming approaches (e.g. high throughput
(HTP) systems that analyse large numbers of samples sim-
ultaneously and in vitro models) compared with more
traditionally used techniques, in order to develop a faster
evaluation of risk. In the longer-term (10–15 years) risk
assessment will require the development of increasingly
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robust modelling approaches to allow a reduced require-
ment for in vivo and in vitro hazard testing, while in the
distant future (>15 years) risk assessment will be increas-
ingly reliant on modelling/in silico approaches, with fo-
cused physicochemical, exposure and hazard testing only
if additional information is required.
Defining the ITS components
For each element of the risk assessment (physicochemi-
cal, exposure and hazard) the essential information re-
quired was defined to generate an Identity (ID) [6].
The Physicochemical ID was defined as ‘the dynamic
pattern of physical and chemical characteristics (iden-
tified using appropriate analytical techniques) associ-
ated with one or several specified NMs during their life
cycle’. This includes identifying detailed physicochemical
descriptors of key inherent features of the NMs in terms
of what they are (composition, size etc.), where NMs go
(biological and environmental fate) and what they do (in-
herent activity of NMs).
The Exposure ID was defined as ‘the pattern of concen-
trations of one or more NMs in different matrices (air,
liquid or solid) and as a function of duration and vari-
ability over time during their life cycle’. This takes into
account both human and environmental exposure routes.
In risk assessment the Exposure ID is critical for linking
the Physicochemical ID to the Hazard ID.
A Hazard ID was defined as ‘the pattern of biological
responses (determined using appropriate combina-
tions of toxicological and ecotoxicological models,
tests and endpoints) associated with one or several
specified NMs’. Human and environmental Hazard IDs
were integrated in order to promote collaboration and
knowledge exchange between the two disciplines. This is
important since it is likely that many similarities exist
between the modes-of-action of NMs underlying tox-
icity, and therefore techniques can be shared to study
hazard impacts.
Grouping was defined as ‘the arrangement of nano-
materials into groups based on common attributes’.
In the context of risk assessment, this could include a
common hazardous physicochemical property, or an ex-
posure potential that infers greater risk. Ranking was de-
fined as ‘assigning a position in a scale’, meaning that,
NMs may be classified based on attributes describing
their potential for exposure (e.g. high dustiness) and/or
their high intrinsic toxicity. Whereas ranking does not
necessarily imply a relationship between the NMs on a
given scale, grouping does infer a relationship in a com-
mon attribute. It is worth noting that groups can be
ranked and ranking can occur within groups.
The risk assessment (RA) framework in the context of
this document was defined as “the entirety of EU law re-
quiring a RA of substances for their safe use as such or
in products/articles and the related guidance”. The RA
framework is therefore considered to be applicable to
NMs, even if they are not always explicitly addressed.
However, some adaptations to risk assessment approaches
and regulations may be required to ensure the safety of
current and future NMs and their applications, as well as
the integration of new tools (e.g. quantitative nano-
structure activity relationships [7,8], or multi-component
decision analysis [9]) used to assess risk.
Prioritising the research needs for the ITS components
The research priorities identified in the project, including
future time-frames, are presented below. Note that the
longer term priorities are not considered less important,
rather that they will require more information to be ad-
dressed before they are satisfied. Therefore work on the
longer term goals needs to start now in order to appropri-
ately frame the short-term research required. This will en-
sure that the outputs from the short-term priorities are
appropriate for development of the longer term priorities.
The following sections summarise research priorities di-
vided according to the elements of the risk assessment, as
Biological impact
Target Biokinetics Cytotoxicity Inflammation Oxidative stress Fibrosis Genotox Carcinogenicity
Lung 381 250 543 207 44 45 246
Liver 76 28 39 19 3 6 23
Spleen/immune 52 19 79 21 4 2 16
CNS 54 20 47 32 2 3 18
GI Tract 29 21 29 12 2 5 19
kidney 30 9 17 6 1 1 4
CV 138 84 219 83 18 10 60
Repro/develop 5 1 6 1 1 2 1
Pleura (retention) 23 23 47 20 4 3 11
Figure 1 A heat map illustrating the number and pattern of nanomaterial publications identified (December 2012) in Web of Science
and PubMed. This particular example focuses on systemic effects identified in human toxicity studies using both in vitro and in vivo approaches. Black
signifies more than 50 publications, grey represents 20–50 publications while white is less than 20. A full set of heat maps for local and systemic effects
for human toxicity as well as for ecotoxicity is provided in the gap analysis at http://www.nano.hw.ac.uk/research-projects/itsnano.html.
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well as grouping/ranking and implementation of the find-
ings into risk assessment frameworks [6].
(i) Physicochemical ID
The Physicochemical ID refers to a set of characteris-
tics, which are likely to change over the life cycle of a
NM, and that can potentially be used for risk assessment
and decision-making purposes. In the short term, tools
are required that include standard/reference materials,
validated instruments and standard protocols to maximise
the cost-effectiveness of physicochemical characterisation.
A library of such tools is needed, so that stakeholders can
tailor the selection of tools to their own personal require-
ments. In the mid-term these tools will contribute to ef-
fective characterisation of materials at different life cycle
stages and in a wide array of complex matrices (e.g. in
products such as composite materials, plastics and food,
but also in different environments such as water, air or
soil). Stakeholders already employ a wide array of physico-
chemical characteristics, but the development, validation
and implementation of novel nano-relevant physico-
chemical descriptors, techniques and instrumentation
may be required. In the long-term, stakeholders will
require further development of the standardised protocols
for detecting, monitoring and characterising NMs
throughout their life cycle, in complex matrices and for
both in vitro and in vivo models. Development of this ex-
panded set of tools will allow the approach to physico-
chemical ID to be flexible, tailored and/or tiered. Finally,
in the distant future, high-quality physicochemical data
for in vitro, in vivo and in silico approaches will be re-
quired to support exposure assessment and hazard identi-
fication (Figure 2).
(ii) Exposure ID
As for the Physicochemical ID, Exposure ID also re-
quires the standardisation of methods for discriminating
NMs from background particles in complex matrices,
throughout their life cycles. This research need should
be retained as a continuous priority over time. In the
short term, for assessing human exposure, research pri-
orities include both inhalation and ingestion routes. The
Figure 2 Proposed research prioritisation for generating an effective PC ID to inform an Intelligent Testing Strategy. The research
priorities are graded across the diagram, with hexagons to the left being of short term-priority (< 5 years) stretching to longer term priorities on
the right (> 15 years). Grey hexagons represent modelling components that will lead to the ITS. The short-term priorities should be considered in
the context of the long-term priorities to ensure that they generate the information needed to provide robust foundations for the
longer-term priorities.
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inhalation research needs to reflect the potential for ex-
posure to workers in the occupational settings, while in-
gestion research reflects both intentional and incidental
exposure to NMs in food and consumer products or at
workplaces due to poor hygiene; dermal research reflects
potential for exposure of consumers using cosmetic
products or other consumer products and of workers in
occupational settings. In parallel, exposure assessment
needs to better define the relationship between exposure
concentration and internal dose. For assessing environ-
mental exposure, the research focus needs to include
identification of long-term accumulation as well as
concentration hotspots in both soils and sediments. In
the mid-term, actual exposure concentrations in the
matrices of different environmental compartments (e.g.
air, water, soil) should be linked to actual exposure. In
addition, robust strategies for sampling and determining
concentrations in appropriate indicator organisms and/
or potentially sensitive environmental compartments
need to be formulated and thoroughly validated. To ac-
celerate physicochemical characterisation, high through-
put (HTP) screening will be essential, while modelling
approaches will be required to reduce the burden of test-
ing. This approach will facilitate grouping of NMs and
modelling their exposure, bioaccumulation and fate
throughout their life cycles. In the distant future the de-
velopment of standardised protocols for multi-metric
and innovative detection tools is essential (Figure 3).
(iii) Hazard ID
Hazard ID generation requires that in vitro and in vivo
models are used to assess the local and systemic effects
of NMs (acute and chronic) and that the mode-of-action
of NMs is identified to better understand what responses
can be used to screen NM toxicity. For Hazard ID gen-
eration, key short-term priorities are to develop dose
metrics that allow determination of the toxicokinetics,
Figure 3 Proposed sequence of events for implementing an exposure testing strategy aimed at grouping and modelling NMs.
The research priorities are graded across the diagram, with hexagons to the left being of short term-priority (< 5 years) stretching to longer term
priorities on the right (> 15 years). Grey hexagons represent modelling components that will lead to the ITS. The short-term priorities should be
considered in the context of the long-term priorities to ensure that they generate the information needed to provide robust foundations for the
longer-term priorities.
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bioavailability and mode of action of NMs. In the mid-
term, appropriate validated in vitro and in vivo models
need to be developed to predict long-term or chronic ef-
fects. These models will also require the development of
reliable biomarkers to estimate exposure and/or estab-
lish indicators for chronic effects. In vivo models will
allow determination of time courses of responses includ-
ing distinction between short and long term effects,
rapid and delayed onset, reversible and irreversible ef-
fects, and underlying mode-of-action. However, the long
term goal is to develop and validate alternative non-
animal models to replace such in vivo models based on
the identification of key biological processes that drive
the adverse effects. In addition to validation of simple
culture systems, there will be a need to generate more
relevant multi-cell and multi-tissue (e.g. gut, endothe-
lium and liver) in vitro models. In the long-term, know-
ledge of the population-level effects, bioaccumulation
and biomagnification of NMs will be required. A com-
mon approach linking mammalian toxicology and
ecotoxicology studies is encouraged. Studies will gener-
ally require robust, appropriate in vitro and in vivo
models of susceptibility to focus on vulnerable individ-
uals or populations. Identification of the mode-of-action
of hazardous effects will allow design of in vitro models
targeting key and relevant processes rather than an in-
direct indicator or something that is simply easy to
measure. In the distant future in vitro HTP testing and
in silico models will allow focused hazard assessment
with an eventual reduction in the burden of testing
(Figure 4).
(iv) Grouping, Ranking and Modelling approaches
Informative grouping/ranking requires precise and ac-
curate Physicochemical-, Hazard-, and Exposure-ID in-
puts. Such data can be used to group or rank materials e.
g. using weight of evidence approaches or structural activ-
ity relationships, which will highly enhance cross material
information flow. In particular, the mode-of-action of
Figure 4 The research steps required to formulate a Hazard ID for incorporation into the ITS. The research priorities are graded across the
diagram, with hexagons to the left being of short term-priority (< 5 years) stretching to longer term and distant priorities on the right (> 15 years).
Grey hexagons represent modelling components that will lead to the ITS. The short-term priorities should be considered in the context of the
long-term priorities to ensure that they generate the information needed to provide robust foundations for the longer-term priorities.
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NMs and how this relates to a defined set of physicochem-
ical characteristics is also crucial in development of group-
ing, ranking or modelling tools. It is envisaged that for
NMs new approaches should be developed for grouping,
ranking and extrapolation/interpolation of results between
species/models and between materials (Figure 5).
Common themes
Specific, detailed recommendations for each aspect of
the strategy are presented under each heading, but as
emphasised, an integrative research effort is required.
Key cross-cutting issues were identified including the
development of standard protocols, reference or stand-
ard materials, and easily adaptable HTP techniques.
This approach will lead to the generation of libraries of
standard protocols to allow a tailored or streamlined ap-
proach to testing. Since this library is likely to be quite
extensive, it will be necessary to support it with a deci-
sion tree or matrix to allow individual stakeholders to
identify the protocols most relevant to them. Different
standard materials may be required for different appli-
cations (e.g. for both calibration of a microscope and
toxicity testing), it would also be desirable to streamline
the range of potential reference and standard materials
so that, where possible, the same material can be used
for multiple applications.
Another cross-cutting issue involves the generation of
HTP techniques for all aspects of NM testing. HTP
techniques are equally relevant to physicochemical, ex-
posure and hazard scenarios. Where possible it will also
be advantageous to make HTP approaches multi-metric,
allowing multiple different endpoints to be assessed in a
single system, e.g. a single HTP system could measure
PC characteristics alongside hazard endpoints, or hazard
alongside exposure.
Cross-cutting issues also include the development and
implementation of: (i) a common language (i.e. shared
ontology, terminology and nomenclature); (ii) comprehen-
sive, user-friendly information-sharing tools (e.g. data-
bases); (iii) synergistically applicable advanced techniques
(by providing, for instance, an efficient research framework
and facilitating access to advance analytical equipment and
qualified, highly trained staff); and (iv) in-depth risk assess-
ment methodologies.
Implementation of the ITS into risk assessment and
regulation
Successful application of the ITS-NANO research priori-
tisation will lead to the generation of relevant information
on NM physicochemical characteristics, hazards and
exposure, including data obtained from in vitro tests,
read-across/grouping/ranking, and in silico hazard and ex-
posure models. Thus, these research outputs will provide
secure, evidence-based foundations for formulating and
implementing ‘best practices’ for risk assessment and for
data management of NMs [6].
Within existing risk assessment frameworks, alternative
to animal testing (e.g. in vitro) and non-testing (e.g. read-
across) methods are already encouraged, provided they
are validated or scientifically justified [10,11]. However,
mid- to long-term issues are foreseen, including the po-
tential need to adapt the current regulatory framework to
accommodate the novel quantitative tools and probabilis-
tic approaches to integrate data from alternative ap-
proaches into a risk assessment. To facilitate this process,
training of risk assessors, regulators and researchers will
be required, along with additional guidance for interpret-
ation and integration of these data and their regulatory ac-
ceptance (Figure 6).
Relationship to parallel strategy activities
A number of other reports address the requirements for
future research in the area of nanomaterial risk assess-
ment. Each report is very insightful and supports the
outcomes of ITS-NANO. For example, the National Re-
search Council (USA) published a report entitled Tox-
icity Testing in the 21st Century: A Vision and Strategy
[2]. The report addresses human toxicity testing rather
than risk assessment and it focuses on chemicals in gen-
eral, rather than NMs. Similar to ITS-NANO the report
predicts expanded use of high- and medium-throughput
in vitro screening assays as well as computational toxi-
cology with reduced animal testing. This is similar to the
ambition proposed by ITS-NANO, however, the options
presented do not develop over time.
Recently, a multi-stakeholder perspective on the use of
alternative testing strategies for assessing NM safety has
been published [3] which stresses the need to move to-
wards reduced animal testing and an increased reliance
on in vitro HTP testing, high content screening and in
silico approaches. Based on a carbon nanotube example,
a tiered approach to testing was proposed in which pre-
dictive modelling and in vitro models would be used to
prioritise the carbon nanotubes to be used for short
term inhalation or instillation experiments with rodents,
which would then be used to design subsequent longer
term (90 day exposure) studies. This approach is based
upon current capabilities and fits nicely into the frame-
work provided by ITS-NANO for development, stream-
lining and improvement in the future.
A strategic research agenda for nanosafety, covering
2015–2025, has recently been published by the NanoSaf-
ety Cluster (European Commission FP7 funded research
projects) [4]. This document provides an overview of all
research needs related to human and environmental
nanosafety. A recommendation for the development of
an ITS is included within this document, which provides
a wider context and framework in which the detailed
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Figure 5 The diagram identifies the components required for the development of a grouping/ranking approach for NMs. Hexagon
colours relate to PC ID (blue), Exposure (brown), Hazard (green), Cross-cutting issues, implementation into a RA framework (grey) and the
final goal of the ITS (white). The diagram is intended to start on the left (NM) and finish on the right, but there is no strict order of passage
between the hexagons to achieve the final goal. The research priorities are graded across the diagram, with hexagons to the left being of short
term-priority (< 5 years) stretching to longer term and distant priorities on the right (> 15 years). It is important to note that contrary to similar
representations in preceding chapters, the hexagons for grouping/ranking are not necessarily intrinsically linked, but contribute to overall progress
towards grouping and/or ranking of NMs as well as modelling. This example is dominated by hazard, but in other scenarios the exposure or
physicochemical priorities may be more dominant.
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ITS-NANO strategy fits, where it can be related to other
wider activities.
Conclusions
ITS-NANO has delivered a detailed, stakeholder driven
and flexible research prioritisation (or strategy) tool,
which identifies specific research needs, suggests con-
nections between areas, and frames this in a time-
perspective. If implemented this research prioritisation
programme would lead to the development of an ITS for
NMs. The strategy is provided in the form of text and
diagrams in order to appeal to, and be useable by a wide
audience. The individual diagrams from each aspect of
the paper can be combined to provide an overall strategy
diagram (Figure 7) that demonstrates how the elements
link together and evolve over time.
The clear and flexible nature of the summary diagrams
allows all stakeholders to identify the key research ques-
tions and priorities that are relevant to their needs and pro-
vides a framework in which to structure and integrate these
activities. The full ITS-NANO report goes even further to
provide detailed outlines of how each research priority
could be addressed. The flexible nature of the diagrams also
allows them to evolve over time as individual research pri-
orities are addressed and new knowledge is acquired.
The usefulness and success of this framework is obvi-
ously dependent on whether it is employed and used
strategically in, for example, calls for research, or imple-
mentation in risk assessment procedures. In fact, following
communication of the ITS-NANO research prioritisation
findings during a webinar to over 70 stakeholders (May
2013; available online: http://www.nano.hw.ac.uk/research-
projects/itsnano.html), the approach used by ITS-NANO
has already been employed in other European Commission
funded projects (e.g. MARINA) and the outputs are being
integrated into new projects (e.g. NANoREG).
Finally, it must be emphasised that in order to ensure a
fast and sustainable development of NMs it is up to the
research community and the other stakeholders to ensure
that their nanosafety-related activities are directed into a
framework, such as the above. A full report is available in




A literature search of Web of Science and Pubmed was
conducted using systematically identified keywords to
cover all relevant aspects of research required for risk
assessment of NMs. These key words included different
descriptors to encompass nanomaterials (e.g. nanoparti-
cle, nanomaterial, nanotube, nanowire, nanorod etc.),
combined with key words relevant to either exposure
(e.g. exposure, uptake, inhalation, ingestion, airborne), hazard
Figure 6 An overview of the risk assessment of NMs in the context of the ITS-NANO research strategy. The grey arrows indicate an
iterative process and the boxes below represent the steps of data generation (for both hazard and exposure data), data collection, interpretation
and integration as well as risk assessment method development and risk management.
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(e.g. cytotoxicity, toxicity, lethality) or physicochemical
characterisation (e.g. size, surface area, crystallinity). Then
heat map tables were generated that described the number
of relevant publications identified relating to different target
species, routes of exposure, physicochemical characteristics
and mode of action. Examples of heat map tables are pro-
vided in Figure 1. Full details of the protocol are described
in the Identification of Knowledge Gaps and Strategic Prior-
ities for Human and Environmental Hazard, Exposure and
Risk Assessment of Engineered Nanomaterials document,
(http://www.nano.hw.ac.uk/research-projects/itsnano.html).
The output of the literature assessment, including heat
maps, was developed into a knowledge gap analysis. On this
basis we identified and listed outstanding research, allowing
for effective risk assessment of NMs especially in relation
to development of an ITS. The gaps were grouped logically
according to subject content, but they were not ranked ac-
cording to priority at this stage. This gap analysis was sup-
ported by an online questionnaire distributed to on-going
EU nanosafety research projects, in order to estimate the
expected knowledge gain within the next few years.
The draft gap analysis was shared with a group of 40
stakeholders representing experts from academia, industry,
regulators, funders and NGOs at a two day workshop in
Edinburgh (September 2012). The experts were asked to
assess whether the gaps identified were appropriate and
whether they corresponded to their experience/knowledge
and/or whether any gaps had been missed. Useful feed-
back was provided to allow a more accurate representation
of current knowledge gaps. The final gap analysis is avail-
able on-line (http://www.nano.hw.ac.uk/research-projects/
itsnano.html).
Structuring the risk assessment paradigm
Based upon the gap analysis, the ITS-NANO team drafted
initial ideas for research prioritisation. It was recognised
that the future risk assessment paradigm for NMs would
follow the structure of the framework currently used for
chemicals, in that it would include an assessment of haz-
ard and exposure. However, the prioritisation document
also discussed how to better incorporate physicochemical
characterisation of NMs into the risk assessment process.
For this reason, during the Edinburgh workshop, the ex-
perts were asked to identify what is necessary to define a
hazard identity (ID), exposure ID and physicochemical ID
for NMs. In addition, ideas were invited with respect to
Figure 7 The diagram illustrates the connections between the identified research priorities, and the implementation of the subsequent
acquired knowledge and methods in the risk evaluation process. Each hexagon represents a priority research need, and each interface a
logical relationship; with black hexagons representing NMs around the outside and the ITS modelling tools in the centre. Between the three
priority research areas (Physicochemical, Exposure and Hazard ID) and the central ITS are the grouping/ranking approaches (bold hexagons)
needed to streamline the data requirements. The blue arrows indicate the direction of research progress over time (from the perimeter of the
diagram towards the core). The outputs of the ITS feed into the risk assessment frameworks at the bottom of the diagram.
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the development of grouping, ranking and modelling ap-
proaches for streamlining testing and implementation into
risk assessment frameworks.
Prioritising the identified research needs
Based upon discussions between the project partners,
along with input from the Edinburgh workshop stake-
holders, the vision and ambitions were identified.
Once the research needs were identified and ordered
with respect to the ITS-NANO vision, a series of draft
hexagon diagrams for hazard identity (ID), exposure ID
and physicochemical ID, as well as for grouping, ranking
and modelling approaches and implementation into risk
assessment frameworks were generated. These included
two types of diagram, the first outlined the information
required to generate each ID, grouping/ranking or im-
plementation of the research outputs into a risk assess-
ment framework. The second series of diagrams outlined
the research required to achieve each ID, grouping/rank-
ing or implementation. A second stakeholder workshop
(Venice, March 2013) was then conducted in which 80
stakeholders were asked to comment on the content of
the draft diagrams. First they refined the information re-
quired to generate each ID and then they prioritised the
research needs. Following the workshop each diagram was
adapted to take into account the stakeholder feedback,
resulting in a clear prioritisation of the research needs.
Concurrent with this prioritisation it was investigated
how such development could be implemented in the
current and future risk assessment regulations.
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